The B2C market for these devices is simply not where the money will be made. The quality of our device is important table stakes, but the HeraCARE SaaS platform and integration with hospitals is the only real game in town, and HMD clearly recognise it.
- Forums
- ASX - By Stock
- Ann: Outstanding Results Achieved in Second JHC Clinical Trial
The B2C market for these devices is simply not where the money...
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HMD (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.003(10.7%) |
Mkt cap ! $12.19M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.9¢ | $26.69K | 885.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 478235 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 800330 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 478235 | 0.029 |
1 | 262750 | 0.028 |
1 | 89999 | 0.027 |
2 | 285000 | 0.024 |
2 | 4884028 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 800330 | 3 |
0.032 | 600000 | 1 |
0.038 | 40000 | 1 |
0.044 | 90000 | 1 |
0.072 | 350000 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |